Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nusano logo — Helping fight cancer by bringing supply stability and innova...

Nusano

Helping fight cancer by bringing supply stability and innovation to medical radioisotopes

Founded 2013 United States Valencia, United States 140 employees Series A Health Care, Health and Wellness +1

General Information

Company Name Nusano
Founded Year 2013
Location United States Valencia, United States
Employees 140
Industries Health Care, Health and Wellness, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Nusano. To contact Nusano, visit nusano.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nusano compare?

A PDF of Nusano and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nusano soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nusano

Nusano, a physics company headquartered in the United States, is focused on addressing the scarcity and unavailability of medical radioisotopes, essential for cancer diagnosis and treatment. The company's slogan, "Helping fight cancer by bringing supply stability and innovation to medical radioisotopes," encapsulates its mission. Nusano's patented technologies and methods aim to revolutionize radioisotope production, ensuring a stable and efficient supply for hospitals and cancer clinics worldwide. The company, founded in 2013, received a Series A investment from Section 32 on 24th October 2018. Nusano's innovative approach not only has the potential to transform cancer care but also offers hope to patients fighting life-threatening diseases.

Business keywords: Radioisotopes, Cancer care, Medical innovation, Supply stability, Nuclear medicine, Radiopharmaceuticals, Particle physics, Medical tracers, Cancer treatment, Advanced medicines, Healthcare supply chain

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
Section 32
Section 32
24 Oct 2018

Nusano Alternatives & Competitors

View All Alternatives
Nusano vs
Cyclotek Pty Ltd
Cyclotek Pty Ltd Australia

Improving patient outcomes with accessible targeted radiopharmaceuticals.

Private Equity
106 employees
Health Care, Logistics
Nusano vs
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company
POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company United States

Accelerating Precision Medicine™

Post-IPO Equity
79 employees
Biopharma, Biotechnology
Nusano vs
Clarity Pharmaceuticals
Clarity Pharmaceuticals Australia

Clarity is developing next-generation products to address the growing need for radiopharmaceuticals...

Venture round
61 employees
Biotechnology, Health Care
View all alternatives

FAQ About Nusano

Helping fight cancer by bringing supply stability and innovation to medical radioisotopes
Nusano was founded in 2013.
Nusano is headquartered in Valencia, United States.
Nusano operates in Health Care, Health and Wellness and Pharmaceutical. Its work centres on Radioisotopes, Cancer care, Medical innovation and Supply stability.
Nusano has approximately 140 employees.
Nusano has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to Nusano include Cyclotek Pty Ltd, POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, Clarity Pharmaceuticals, ARTBIO, NorthStar Medical Radioisotopes, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nusano and Cyclotek Pty Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nusano, https://bouncewatch.com/company/nusano, updated 6 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes